Psychotic-like Symptoms Completed Phase 1 Trials for Ketamine (DB01221)

IndicationStatusPhase
DBCOND0064706 (Psychotic-like Symptoms)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01892189Effects of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy Male AdultsBasic Science